Citation

Pavlis MB, Lieblich L. Cutis 2013; 92(1): 33-34.

Affiliation

181 N Belle Mead Rd, Ste 5, East Setauket, NY 11733, USA. michelle.pavlis@gmail.com.

Copyright

(Copyright © 2013, Quadrant HealthCom)

DOI

unavailable

PMID

23961523

Abstract

Isotretinoin is approved by the US Food and Drug Administration for the treatment of severe recalcitrant nodular acne. Mucocutaneous toxicity is the most commonly observed side effect of isotretinoin use. Because atrophy and skin fragility may occur while taking isotretinoin, most warnings recommend avoidance of cosmetic procedures, such as dermabrasion, laser treatments, waxing, and chemical peels. We report a case of isotretinoin-induced skin fragility in a 16-year-old adolescent boy who presented with an unusual amount of skin erosions and excoriations on his face during wrestling season. We propose that it may be prudent to advise athletes who are involved in contact sports that skin fragility and increased erosions may occur during or after their course of treatment with isotretinoin.

Language: en